SCHEMBL10590546

SCHEMBL10590546

COC1=CC(=O)C(Cl)C2=C1Nc1ccc(OC)cc1S2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SNCA P37840 3/20 0.50
▸ NOX1 Q9Y5S8 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAOA P21397 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.35
▸ PDE3B Q13370 2/20 0.33
▸ PDE3A Q14432 2/20 0.33
▸ LRRK2 Q5S007 2/20 0.33
▸ SLC2A1 P11166 1/20 0.33
▸ CA2 P00918 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10569969 0.79 SNCA (0.50) SNCANOX1MAPTMEN1KMT2A
SCHEMBL10592270 0.78 NOX1 (0.49) SNCANOX1MAPTMEN1KMT2A
SCHEMBL10593152 0.73 SNCA (0.52) SNCANOX1MAPTMEN1KMT2A
SCHEMBL10590962 0.73 EPHX2 (0.41) NOX1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL2987616 0.71 SNCA (0.50) SNCANOX1MAPTMEN1KMT2A
SCHEMBL10590992 0.70 MAPT (0.44) SNCANOX1MAPTMEN1KMT2A
SCHEMBL3489840 0.69 SNCA (1.00) SNCANOX1MAPTMEN1KMT2A
SCHEMBL29636455 0.69 SNCA (1.00) SNCANOX1MAPTMEN1KMT2A
SCHEMBL11129828 0.69 NOX1 (0.41) NOX1MAPT
SCHEMBL9813228 0.66 SNCA (0.52) SNCANOX1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0115394-B1 PHENOTHIAZONE DERIVATIVES AND ANALOGS MERCK FROSST CANADA INC. (CA) 1989-06-28 — — EP disclosed
EP-0155623-A2 Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition MERCK & CO. INC. (US) 1985-09-25 — — EP disclosed
EP-0115394-A2 Phenothiazone derivatives and analogs MERCK FROSST CANADA INC. (CA) 1984-08-08 — — EP disclosed
Send feedback